MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.13) by 46.15 percent. This is a 38.71 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $24.30 million which beat the analyst consensus estimate of $24.11 million by 0.79 percent. This is a 22.52 percent increase over sales of $19.83 million the same period last year.